Servier is a global pharmaceutical group, led by a Foundation. With a strong geographical presence and a revenue of €4.9 billion in 2021/2022 generated in 150 countries, Servier employs 21,400 people worldwide. As an independent group, Servier invests more than 20% of its revenue each year in research and development. To accelerate therapeutic innovation for the benefit of patients, the Group engages in open and collaborative innovation with academic partners, other pharmaceutical companies, and biotechnology firms. Additionally, it integrates the patient's voice at the heart of its activities, from research to support beyond medication.